Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT)
2023-07-31 17:05
GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME
2023-07-31 15:00
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid)
2023-07-31 13:20
J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Dosing of First Patient in the Global Multi-center Phase 1/2 Clinical Study began
2023-07-31 13:10
Akeso Inc. Published 2023 Interim Results Positive Profit Alert
2023-07-31 12:33
NMPA and FDA Approved the First-in-Human Clinical Trial Applications to Evaluate LBL-034, An Anti-GPRC5D/CD3 Bispecific Antibody Developed by Leads Biolabs, in Relapsed/Refractory Multiple Myeloma
2023-07-31 12:09
VARON Reiterates Its Commitment to Brand Value and Its Determination to Reshape the Oxygen Concentrator Industry
2023-07-28 22:20
Dr. Dapeng Liu: ChatGPT Redefines Medical Device As AI Medical Milestones
2023-07-28 21:20
Fresh2 Group Ltd. Completes Acquisition of SpeedIn INC, a Delivery Service Provider
2023-07-28 21:00
Derm Favorite Skincare Brand COSRX's Revenue Rises 138% YoY in the First Half of 2023
2023-07-28 21:00
HANQUYOU Marks 3rd Anniversary with Brilliant Achievements
2023-07-28 15:27
Wuan Ankang Hospital's Innovative Tumor Treatment Attracts Many Patients
2023-07-28 14:35
Empowering Regenerative Medicine: 3A-GTP Technology Ushers in a New Epoch
2023-07-28 10:00
2023 Tsinghua Amgen Scholars Program Kicks Off
2023-07-27 21:00
HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
2023-07-27 19:00
AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine
2023-07-27 14:00
GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients
2023-07-27 08:53
PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
2023-07-26 20:00
Samsung Biologics Reports Second Quarter 2023 Financial Results
2023-07-26 15:23
Lunit Accelerates Expansion Across Middle East by Bringing AI Solution to Dr. Sulaiman Al Habib Medical Group, Middle East's Largest Healthcare Provider
2023-07-26 14:00
1
85
86
87
88
89
801